Organon executive converts 21,872 stock units
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Organon & Co. (OGN) reported that its Head of Mfg & Supply, Juliana Papa Drinane, converted 21,872 restricted stock units into 21,872 common shares on November 13, 2026. Each RSU converts into one common share; her reported direct RSU balance afterward was 43,744.
On the same date, 7,492 common shares were delivered or withheld for payment of exercise price or tax liability, at a reported per-share price of $13.90. The units were part of 65,616 RSUs granted November 13, 2025, with one-third vesting each year and a final vesting date of November 13, 2028. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F1, F2 | 21,872 | $0.00 | $0.00 |
| Exercise | Common Stock | 21,872 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 7,492 | $13.90 | $104K |
Footnotes (2)
- F1. Each Restricted Stock Unit ("RSU") converts into one share of Organon & Co. common stock.
- F2. 65,616 RSUs were granted on November 13, 2025, and one-third vest each year with the final vesting date being November 13, 2028.
Key Figures
Key Terms
Restricted Stock Unit financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Organon (OGN) Head of Mfg & Supply Juliana Papa Drinane report on November 13, 2026?
What is the vesting schedule for Organon (OGN) Head of Mfg & Supply Juliana Papa Drinane’s RSUs?
AI-generated analysis. How Rhea-AI works. Not financial advice.